Diagnostic Value of CD56 and CD200 Co-Expression by Flow Cytometry in Neuroendocrine Carcinomas.

Published 03/24/2026

Research record: Diagnostic Value of CD56 and CD200 Co-Expression by Flow Cytometry in Neuroendocrine Carcinomas.

Published in Int J Lab Hematol; first publication date 2026-03-24. PMID 41873856.

This literature update records publication metadata from Europe PMC. Consult the original publication for its methods, findings and limitations.

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-03-24

Updated

2026-10-20

Disclaimer

professional use

References